Skip to main content
Clinical Trials/NCT03567369
NCT03567369UnknownNot Applicable

Comparative Study of the Preoperative Efficacy of Traumeel Versus Dexamethasone in Control of Pain, Swelling and Trismus After Mandibular Third Molar Extractions

Federal University of the Valleys of Jequitinhonha and Mucuri1 site in 1 country17 target enrollmentStarted: April 2, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
17
Locations
1
Primary Endpoint
Postoperative sequelae following thir molar extraction

Study Overview

Brief Summary

To compare the efficacy of intramuscular injection of two anti-inflammatory drugs, Traumeel and Dexamethasone, used in the control of postoperative complications pain, edema and trismus after third molar extraction mandibular

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with indication of asymptomatic bilateral extractions of lower third molars;
  • Aged 18 years or older;
  • Have a good health and no disease.

Exclusion Criteria

  • Patients with history of any medication treatment within 15 days before the beginning of the research, history of allergy to the drugs, substances or materials used in this study, pregnancy or lactation

Arms & Interventions

Dexamethasone

Experimental

Dexamethasone 4,0 mg / mL

Intervention: Dexamethasone (Drug)

Traumeel S

Experimental

Traumeel 2,2 mg / mL

Intervention: Traumeel S (Drug)

Outcomes

Primary Outcomes

Postoperative sequelae following thir molar extraction

Time Frame: up to seven days postoperative

During the postoperative intervals of 24, 48 and 72 hours and seven days, the swelling was determined using linear measures in the face and trismus by maximum mouth opening. The postoperative pain was self-recorded by the patient using visual analogue scale in 72 hours with an interval of eight hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Federal University of the Valleys of Jequitinhonha and Mucuri
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marcos Luciano Pimenta Pinheiro

Principal Investigator

Federal University of the Valleys of Jequitinhonha and Mucuri

Study Sites (1)

Loading locations...

Similar Trials

92/5000 Preoperative Efficacy of Traumeel... | Clinical Trial